| scholarly article | Q13442814 |
| P50 | author | Domenico Corrado | Q56529119 |
| Hugh Calkins | Q67190496 | ||
| P2093 | author name string | Frank Marcus | |
| P2860 | cites work | Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene | Q24656100 |
| Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: An International Task Force Consensus Statement | Q26799143 | ||
| Compound and digenic heterozygosity predicts lifetime arrhythmic outcome and sudden cardiac death in desmosomal gene-related arrhythmogenic right ventricular cardiomyopathy | Q28299300 | ||
| Arrhythmogenic right ventricular cardiomyopathy/dysplasia clinical presentation and diagnostic evaluation: results from the North American Multidisciplinary Study | Q30489889 | ||
| Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. | Q33150735 | ||
| Natural history and risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy | Q33151854 | ||
| Arrhythmogenic right ventricular dysplasia: a United States experience | Q33153393 | ||
| Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia | Q33159168 | ||
| Prognostic predictors in arrhythmogenic right ventricular cardiomyopathy: results from a 10-year registry. | Q53081386 | ||
| Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. | Q55638651 | ||
| Age- and Training-Dependent Development of Arrhythmogenic Right Ventricular Cardiomyopathy in Heterozygous Plakoglobin-Deficient Mice | Q57627890 | ||
| Long-Term Efficacy of Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy | Q57736293 | ||
| Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention | Q84974205 | ||
| Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated mutation carriers | Q86589091 | ||
| Long-Term Outcome With Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy | Q86644555 | ||
| Potentially Lethal Ventricular Arrhythmias and Heart Failure in Arrhythmogenic Right Ventricular Cardiomyopathy: What Are the Differences Between Men and Women? | Q88668354 | ||
| Arrhythmogenic right ventricular cardiomyopathy 2012: diagnostic challenges and treatment | Q33161666 | ||
| Predictors of appropriate ICD therapy in patients with arrhythmogenic right ventricular cardiomyopathy: long term experience of a tertiary care center | Q33161842 | ||
| Usefulness of inducible ventricular tachycardia to predict long-term adverse outcomes in arrhythmogenic right ventricular cardiomyopathy | Q33161961 | ||
| Different prognostic value of functional right ventricular parameters in arrhythmogenic right ventricular cardiomyopathy/dysplasia | Q33163807 | ||
| Usefulness of electrocardiographic parameters for risk prediction in arrhythmogenic right ventricular dysplasia | Q33164255 | ||
| Phenotypic expression is a prerequisite for malignant arrhythmic events and sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy. | Q33165969 | ||
| Clinical Presentation and Outcomes by Sex in Arrhythmogenic Right Ventricular Cardiomyopathy: Findings from the North American ARVC Registry | Q33166782 | ||
| Arrhythmogenic Right Ventricular Cardiomyopathy: Clinical Course and Predictors of Arrhythmic Risk. | Q33167985 | ||
| Long-term follow-up in patients with arrhythmogenic right ventricular disease | Q33168115 | ||
| Cardiac phenotype and long-term prognosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia patients with late presentation. | Q33168279 | ||
| Implantable Cardioverter-Defibrillator Therapy in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Predictors of Appropriate Therapy, Outcomes, and Complications | Q33168709 | ||
| Update of arrhythmogenic right ventricular dysplasia | Q34126194 | ||
| Right ventricular dysplasia: a report of 24 adult cases | Q34714742 | ||
| Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International S | Q34727600 | ||
| Vigorous physical activity impairs myocardial function in patients with arrhythmogenic right ventricular cardiomyopathy and in mutation positive family members. | Q34782131 | ||
| Exercise has a disproportionate role in the pathogenesis of arrhythmogenic right ventricular dysplasia/cardiomyopathy in patients without desmosomal mutations. | Q35115127 | ||
| Ventricular arrhythmias in the North American multidisciplinary study of ARVC: predictors, characteristics, and treatment | Q35735685 | ||
| Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: A systematic review and meta-analysis of inappropriate shocks and complications | Q35781029 | ||
| Association of competitive and recreational sport participation with cardiac events in patients with arrhythmogenic right ventricular cardiomyopathy: results from the North American multidisciplinary study of arrhythmogenic right ventricular cardiom | Q35847506 | ||
| Task Force 8: classification of sports | Q36101187 | ||
| Central role for GSK3β in the pathogenesis of arrhythmogenic cardiomyopathy | Q36884231 | ||
| Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. | Q37259910 | ||
| Incremental value of cardiac magnetic resonance imaging in arrhythmic risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. | Q37676235 | ||
| Cardiac MR findings and potential diagnostic pitfalls in patients evaluated for arrhythmogenic right ventricular cardiomyopathy | Q38259638 | ||
| Evaluation of Structural Progression in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy | Q39015719 | ||
| Comparison of Features of Fatal Versus Nonfatal Cardiac Arrest in Patients With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy | Q40200753 | ||
| A Prospective Study of Sudden Cardiac Death among Children and Young Adults | Q40687793 | ||
| Etiology of Sudden Death in Sports: Insights From a United Kingdom Regional Registry. | Q40766721 | ||
| Clinical Presentation, Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patients and Family Members | Q41144205 | ||
| Risk Stratification in Arrhythmic Right Ventricular Cardiomyopathy Without Implantable Cardioverter-Defibrillators. | Q41552188 | ||
| Subcutaneous implantable cardioverter-defibrillator Post-Approval Study: Clinical characteristics and perioperative results. | Q45059087 | ||
| Electrocardiographic predictors of electroanatomic scar size in arrhythmogenic right ventricular cardiomyopathy: implications for arrhythmic risk stratification | Q47212075 | ||
| Sex hormones affect outcome in arrhythmogenic right ventricular cardiomyopathy/dysplasia: from a stem cell derived cardiomyocyte-based model to clinical biomarkers of disease outcome | Q48251222 | ||
| Risk stratification of arrhythmogenic right ventricular cardiomyopathy based on signal averaged electrocardiograms | Q48296011 | ||
| Nationwide (Denmark) study of symptoms preceding sudden death due to arrhythmogenic right ventricular cardiomyopathy. | Q50560818 | ||
| Outcomes and ventricular tachycardia recurrence characteristics after epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy. | Q51023298 | ||
| Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia. | Q51329457 | ||
| Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. | Q51674425 | ||
| Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients. | Q51704331 | ||
| Safety of American Heart Association-recommended minimum exercise for desmosomal mutation carriers. | Q52920761 | ||
| Arrhythmogenic Right Ventricular Cardiomyopathy. | Q52932634 | ||
| P433 | issue | 21 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | arrhythmogenic right ventricular cardiomyopathy | Q2555727 |
| P304 | page(s) | 2068-2082 | |
| P577 | publication date | 2017-11-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy. | |
| P478 | volume | 136 |
| Q97648957 | Characteristics and prognostic implications of tricuspid regurgitation in patients with arrhythmogenic cardiomyopathy |
| Q92376906 | Clinical features and arrhythmic complications of patients with pediatric-onset arrhythmogenic right ventricular dysplasia |
| Q99613010 | Comparison of different prediction models for the indication of implanted cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy |
| Q90021422 | How to interpret right ventricular remodeling in athletes |
| Q60046136 | Identification of Crucial Genes and Pathways in Human Arrhythmogenic Right Ventricular Cardiomyopathy by Coexpression Analysis |
| Q90441553 | Left Ventricular Involvement in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Predicts Adverse Clinical Outcomes: A Cardiovascular Magnetic Resonance Feature Tracking Study |
| Q92155367 | Missing Link between Molecular Aspects of Ventricular Arrhythmias and QRS Complex Morphology in Left Ventricular Hypertrophy |
| Q92482824 | Outcomes and management of arrhythmogenic right ventricular cardiomyopathy in pregnancy: a case report |
| Q58541337 | PKP2 and DSG2 genetic variations in Latvian arrhythmogenic right ventricular dysplasia/cardiomyopathy registry patients |
| Q89734064 | Paediatric cardiomyopathies: echocardiographic diagnosis, clinical profile, and demographic characteristics: the experience of a tertiary referral centre for Latin American paediatric cardiology |
| Q95940975 | Plasma testosterone and arrhythmic events in male patients with arrhythmogenic right ventricular cardiomyopathy |
| Q90668307 | Relationship Between Electrocardiographic Findings and Cardiac Magnetic Resonance Phenotypes in Arrhythmogenic Cardiomyopathy |
| Q64230001 | Sudden Death and Left Ventricular Involvement in Arrhythmogenic Cardiomyopathy |
| Q64074155 | The Brazilian Society of Cardiology and Brazilian Society of Exercise and Sports Medicine Updated Guidelines for Sports and Exercise Cardiology - 2019 |
| Q93171296 | The Netherlands Arrhythmogenic Cardiomyopathy Registry: design and status update |
| Q93054075 | Turkish Society of Cardiology consensus report on recommendations for athletes with high-risk genetic cardiovascular diseases or implanted cardiac devices |
| Q58578329 | Variants: Association With Cardiac Disorders |
| Q91645466 | Whole-Exome Sequencing Identified a De Novo Mutation of Junction Plakoglobin (p.R577C) in a Chinese Patient with Arrhythmogenic Right Ventricular Cardiomyopathy |
Search more.